摘要
心脏淀粉样变性主要有免疫球蛋白轻链型和转甲状腺素蛋白型两个亚型,病情进展迅速,预后差。心脏淀粉样变性早期诊治至关重要,但是临床漏诊和误诊率高。加拿大心血管学会联合加拿大心力衰竭学会发表的《心脏淀粉样变性患者评估和治疗的联合立场声明》就心脏淀粉样变性患者的流行病学、临床诊断和治疗进行了较为全面的阐述,本文拟就其重点内容进行介绍。
Cardiac amyloidosis mainly has two subtypes:the immunoglobulin light chains amyloidosis and the transthyretin amyloidosis.Cardiac amyloidosis develops rapidly and the prognosis is poor.Early diagnosis is critical.Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis published this year elaborated epidemiology,diagnosis and therapy.The core contents were described in this paper.
作者
潘小宏
马群超
田庄
PAN Xiaohong;MA Qunchao;TIAN Zhuang(Department of Cardiology,the Second Affiliated Hospital of Zhejiang University School of Medcine,Hangzhou 310009,China)
出处
《心电与循环》
2020年第4期321-325,共5页
Journal of Electrocardiology and Circulation
关键词
心脏淀粉样变性
诊断
治疗
Cardiac amyloidosis
Diagnosis
Treatment
